Ledger.Open graph →
SEC Form D · filed October 6, 2017

RELMADA THERAPEUTICS, INC

Offering
$6.9M
Sold
$6.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Charles Casamento · New York, NYDirectorPaul Kelly · New York, NYDirectorSergio Traversa · New York, NYExec · DirectorMaged Shenouda · New York, NYDirectorJoseph Esteves · East Brunswick, NJDirectorInvestments Minetta · Brooklyn, NYDirectorLynn Perry · Atlanta, GADirectorJohn King · East Brunswick, NJExec · DirectorRichard R. Gray · Coppell, TXExec · DirectorKevin R. Westfall · Coppell, TXDirectorDenmar R. Dixon · Coppell, TXDirectorJoseph R. Reece · Coppell, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗